Global Transcatheter Mitral Valve Replacement (TMVR) Market: 2017-2022 Edition
Scope of the Report
The report entitled “Global Transcatheter Mitral Valve Replacement (TMVR) Market: 2017-2022 Edition”, provides analysis of the global TMVR market, with detailed analysis of market size and growth, penetration, market share and economic impact of the industry. The analysis includes the market by value, by volume, by segments and by penetration.
The report also includes the detailed analysis of the regional TMVR market of the following regions: The US and Europe. The analysis in this segment is done by penetration, by segments, by value and by volume.
Growth of the overall global TMVR market has also been forecasted for the years 2017-2022, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. Edward Lifesciences, Medtronic, and Abbott Laboratories are some of the key players operating in the global TMVR market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.
Country Coverage
The mitral valve allows the passage to oxygenated blood from lest atrium (LA) to the left ventricle (LV) and prevent the backflow of blood back into the left atrium. Mitral Regurgitation (MR) is a valve disorder where during heart contraction, blood leaks backward through the mitral valve. This reduces the amount of blood pumped through the body, which leads to declining heart function and heart failure, over the time.
The causes of MR disease are congenital heart disorder, rheumatic fever, trauma, any other heart disease, radiation therapy, etc. The treatments available for MR disease are surgical repair, drug treatment and replacement. There are two types of MR: Degenerative MR (DMR) and Functional MR (FMR). The DMR and FMR can further be subdivided into many types.
There are different approaches for replacement surgery, depending upon the type of MR disease. The TMVR market is in very early stage at this moment, with many companies developing their TMVR devices. The commercial TMVR devices are expected to be launched in next 2-3 years.
Currently, the global TMVR market is in early stage, but is expected to increase at high growth rates during the forecasted period (2017-2022). The global TMVR market is supported by various growth drivers, such as aging population, high number of cases of congenital heart defects, rheumatic fever, low survival rate of surgical repair in FMR patients, etc. Yet, the market faces certain challenges, such as, complexity in design, success of repair surgery in DMR patients, high number of patients not referred for surgery, etc.
The report entitled “Global Transcatheter Mitral Valve Replacement (TMVR) Market: 2017-2022 Edition”, provides analysis of the global TMVR market, with detailed analysis of market size and growth, penetration, market share and economic impact of the industry. The analysis includes the market by value, by volume, by segments and by penetration.
The report also includes the detailed analysis of the regional TMVR market of the following regions: The US and Europe. The analysis in this segment is done by penetration, by segments, by value and by volume.
Growth of the overall global TMVR market has also been forecasted for the years 2017-2022, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. Edward Lifesciences, Medtronic, and Abbott Laboratories are some of the key players operating in the global TMVR market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.
Country Coverage
- The US
- Europe
- Edward Lifescience Incorporation
- Abbott Laboratories
- Medtronic
The mitral valve allows the passage to oxygenated blood from lest atrium (LA) to the left ventricle (LV) and prevent the backflow of blood back into the left atrium. Mitral Regurgitation (MR) is a valve disorder where during heart contraction, blood leaks backward through the mitral valve. This reduces the amount of blood pumped through the body, which leads to declining heart function and heart failure, over the time.
The causes of MR disease are congenital heart disorder, rheumatic fever, trauma, any other heart disease, radiation therapy, etc. The treatments available for MR disease are surgical repair, drug treatment and replacement. There are two types of MR: Degenerative MR (DMR) and Functional MR (FMR). The DMR and FMR can further be subdivided into many types.
There are different approaches for replacement surgery, depending upon the type of MR disease. The TMVR market is in very early stage at this moment, with many companies developing their TMVR devices. The commercial TMVR devices are expected to be launched in next 2-3 years.
Currently, the global TMVR market is in early stage, but is expected to increase at high growth rates during the forecasted period (2017-2022). The global TMVR market is supported by various growth drivers, such as aging population, high number of cases of congenital heart defects, rheumatic fever, low survival rate of surgical repair in FMR patients, etc. Yet, the market faces certain challenges, such as, complexity in design, success of repair surgery in DMR patients, high number of patients not referred for surgery, etc.
1. EXECUTIVE SUMMARY
2. INTRODUCTION
2.1 Heart Valves: An Overview
2.2 Mitral Regurgitation: An Overview
2.2.1 Transcatheter Mitral Valve Timeline
2.2.2 Types of MR
2.2.3 MR Clinical Guidelines
2.3 Aortic Valve v/s Mitral Valve
3. MARKET SIZING
3.1 Global Mitral Regurgitation Market: An Analysis
3.1.1 Global MR Market by Number of Patients
3.1.2 Global MR Market by Patient Severity
3.2 Global Degenerative Mitral Regurgitation Market: An Analysis
3.2.1 Global DMR Market by Number of Patients and Prevalence of TMVR
3.3 Global Functional Mitral Regurgitation Market: An Analysis
3.3.1 Global FMR Market by Number of Patients and Prevalence of TMVR
3.4 Global TMVR Market: An Analysis
3.4.1 Global TMVR Market by Value
3.4.2 Global TMVR Market by Volume
4. REGIONAL MARKET ANALYSIS
4.1 The US TMVR Market: An Analysis
4.1.1 The US MR Market by Number of Patients and Patient Severity
4.1.2 The US DMR Market by Number of Patients and Prevalence of TMVR
4.1.3 The US FMR Market by Number of Patients and Prevalence of TMVR
4.1.4 The US TMVR Market by Value and Volume
4.2 Europe TMVR Market: An Analysis
4.2.1 Europe MR Market by Number of Patients and Patient Severity
4.2.2 Europe DMR Market by Number of Patients and Prevalence of TMVR
4.2.3 Europe FMR Market by Number of Patients and Prevalence of TMVR
4.2.4 Europe TMVR Market by Value and Volume
5. COMPETITIVE LANDSCAPE
5.1 Global TMVR Market by Players
5.2 Global TMVR Market by Key Players
5.3 Comparison of Key Players in The Global TMVR Market by Design
5.4 Global TMVR Market Players by Sales
6. COMPANY PROFILING
6.1 Edward Lifecsiences Incorporation
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategy
6.2 Abbott Laboratories
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategy
6.3 Medtronic
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategy
2. INTRODUCTION
2.1 Heart Valves: An Overview
2.2 Mitral Regurgitation: An Overview
2.2.1 Transcatheter Mitral Valve Timeline
2.2.2 Types of MR
2.2.3 MR Clinical Guidelines
2.3 Aortic Valve v/s Mitral Valve
3. MARKET SIZING
3.1 Global Mitral Regurgitation Market: An Analysis
3.1.1 Global MR Market by Number of Patients
3.1.2 Global MR Market by Patient Severity
3.2 Global Degenerative Mitral Regurgitation Market: An Analysis
3.2.1 Global DMR Market by Number of Patients and Prevalence of TMVR
3.3 Global Functional Mitral Regurgitation Market: An Analysis
3.3.1 Global FMR Market by Number of Patients and Prevalence of TMVR
3.4 Global TMVR Market: An Analysis
3.4.1 Global TMVR Market by Value
3.4.2 Global TMVR Market by Volume
4. REGIONAL MARKET ANALYSIS
4.1 The US TMVR Market: An Analysis
4.1.1 The US MR Market by Number of Patients and Patient Severity
4.1.2 The US DMR Market by Number of Patients and Prevalence of TMVR
4.1.3 The US FMR Market by Number of Patients and Prevalence of TMVR
4.1.4 The US TMVR Market by Value and Volume
4.2 Europe TMVR Market: An Analysis
4.2.1 Europe MR Market by Number of Patients and Patient Severity
4.2.2 Europe DMR Market by Number of Patients and Prevalence of TMVR
4.2.3 Europe FMR Market by Number of Patients and Prevalence of TMVR
4.2.4 Europe TMVR Market by Value and Volume
5. COMPETITIVE LANDSCAPE
5.1 Global TMVR Market by Players
5.2 Global TMVR Market by Key Players
5.3 Comparison of Key Players in The Global TMVR Market by Design
5.4 Global TMVR Market Players by Sales
6. COMPANY PROFILING
6.1 Edward Lifecsiences Incorporation
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategy
6.2 Abbott Laboratories
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategy
6.3 Medtronic
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategy
LIST OF FIGURES
Figure 1: Transcatheter Mitral Valve Timeline
Figure 2: Transcatheter Mitral Valve Clinical Guidelines
Figure 3: Global MR Market by Number of Patients; 2014-2016 (Million)
Figure 4: Global MR Market by Number of Patients; 2017-2022 (Million)
Figure 5: Global MR Market by Patient Severity and Eligibility for Treatment; 2014-2016
Figure 6: Global MR Market by Patient Severity and Eligibility for Treatment; 2017-2022
Figure 7: Global DMR Market by Number of Patients Surgically Treated and Prevalence of TMVR; 2014-2022
Figure 8: Global DMR Market by Number of High Risk Patients and Prevalence of TMVR; 2014-2022
Figure 9: Global FMR Market by Number of Patients Surgically Treated and Prevalence of TMVR; 2014-2021
Figure 10: Global FMR Market by Number of High Risk Patients and Prevalence of TMVR; 2014-2021
Figure 11: Global TMVR Market by Value; 2014-2016 (THE US$ Million)
Figure 12: Global TMVR Market by Value; 2017-2022 (THE US$ Million)
Figure 13: Global TMVR Market by Volume; 2014-2016 (Units)
Figure 14: Global TMVR Market by Volume; 2017-2022 (Units)
Figure 15: The US MR Market by Number of Patients; 2014-2022 (Million)
Figure 16: The US MR Market by Patient Severity; 2014-2022
Figure 17: The US DMR Market by Number of Patients Surgically Treated and Prevalence of TMVR; 2014-2022
Figure 18: The US DMR Market by Number of High Risk Patients and Prevalence of TMVR; 2014-2022
Figure 19: The US FMR Market by Number of Patients Surgically Treated and Prevalence of TMVR; 2014-2022
Figure 20: The US FMR Market by Number of High Risk Patients and Prevalence of TMVR; 2014-2022
Figure 21: The US TMVR Market by Value ; 2016-2022 (THE US$ Million
Figure 22: The US TMVR Market by Volume; 2016-2022 (Units)
Figure 23: Europe MR Market by Number of Patients; 2014-2022 (Million)
Figure 24: Europe MR Market by Patient Severity; 2014-2022 (Million)
Figure 25: Europe DMR Market by Number of Patients Surgically Treated and Prevalence of TMVR; 2014-2022
Figure 26: Europe High Risk DMR Market by Number of Patients and Prevalence of TMVR; 2014-2022
Figure 27: Europe FMR Market by Number of Patients Surgically Treated and Prevalence of TMVR; 2014-2022
Figure 28: Europe High Risk FMR Market by Number of Patients and Prevalence of TMVR; 2014-2022
Figure 29: Europe TMVR Market by Value; 2014-2022 (THE US$ Million)
Figure 30: Europe TMVR Market by Volume; 2014-2022 (Units)
Figure 31: Global TMVR Market by Top Four Players; 2016 (THE US$ Billion)
Figure 32: Edward Lifesciences Net sales; 2012-2016 (THE US$ Billion)
Figure 33: Edward Lifesciences Net sales by Segments; 2016 (Percentage, %)
Figure 34: Edward Lifesciences Net sales by Regions; 2016 (Percentage, %)
Figure 35: Abbott Laboratories Net Sales; 2012-2016 (THE US$ Billion)
Figure 36: Abbott Laboratories Net Sales by Segments; 2016 (Percentage, %)
Figure 37: Medtronic Net Sales; 2012-2016 (THE US$ Billion)
Figure 38: Medtronic Net Sales by Segments; 2016 (Percentage, %)
Figure 39: Medtronic Net Sales by Regions; 2016 (Percentage, %)
Figure 1: Transcatheter Mitral Valve Timeline
Figure 2: Transcatheter Mitral Valve Clinical Guidelines
Figure 3: Global MR Market by Number of Patients; 2014-2016 (Million)
Figure 4: Global MR Market by Number of Patients; 2017-2022 (Million)
Figure 5: Global MR Market by Patient Severity and Eligibility for Treatment; 2014-2016
Figure 6: Global MR Market by Patient Severity and Eligibility for Treatment; 2017-2022
Figure 7: Global DMR Market by Number of Patients Surgically Treated and Prevalence of TMVR; 2014-2022
Figure 8: Global DMR Market by Number of High Risk Patients and Prevalence of TMVR; 2014-2022
Figure 9: Global FMR Market by Number of Patients Surgically Treated and Prevalence of TMVR; 2014-2021
Figure 10: Global FMR Market by Number of High Risk Patients and Prevalence of TMVR; 2014-2021
Figure 11: Global TMVR Market by Value; 2014-2016 (THE US$ Million)
Figure 12: Global TMVR Market by Value; 2017-2022 (THE US$ Million)
Figure 13: Global TMVR Market by Volume; 2014-2016 (Units)
Figure 14: Global TMVR Market by Volume; 2017-2022 (Units)
Figure 15: The US MR Market by Number of Patients; 2014-2022 (Million)
Figure 16: The US MR Market by Patient Severity; 2014-2022
Figure 17: The US DMR Market by Number of Patients Surgically Treated and Prevalence of TMVR; 2014-2022
Figure 18: The US DMR Market by Number of High Risk Patients and Prevalence of TMVR; 2014-2022
Figure 19: The US FMR Market by Number of Patients Surgically Treated and Prevalence of TMVR; 2014-2022
Figure 20: The US FMR Market by Number of High Risk Patients and Prevalence of TMVR; 2014-2022
Figure 21: The US TMVR Market by Value ; 2016-2022 (THE US$ Million
Figure 22: The US TMVR Market by Volume; 2016-2022 (Units)
Figure 23: Europe MR Market by Number of Patients; 2014-2022 (Million)
Figure 24: Europe MR Market by Patient Severity; 2014-2022 (Million)
Figure 25: Europe DMR Market by Number of Patients Surgically Treated and Prevalence of TMVR; 2014-2022
Figure 26: Europe High Risk DMR Market by Number of Patients and Prevalence of TMVR; 2014-2022
Figure 27: Europe FMR Market by Number of Patients Surgically Treated and Prevalence of TMVR; 2014-2022
Figure 28: Europe High Risk FMR Market by Number of Patients and Prevalence of TMVR; 2014-2022
Figure 29: Europe TMVR Market by Value; 2014-2022 (THE US$ Million)
Figure 30: Europe TMVR Market by Volume; 2014-2022 (Units)
Figure 31: Global TMVR Market by Top Four Players; 2016 (THE US$ Billion)
Figure 32: Edward Lifesciences Net sales; 2012-2016 (THE US$ Billion)
Figure 33: Edward Lifesciences Net sales by Segments; 2016 (Percentage, %)
Figure 34: Edward Lifesciences Net sales by Regions; 2016 (Percentage, %)
Figure 35: Abbott Laboratories Net Sales; 2012-2016 (THE US$ Billion)
Figure 36: Abbott Laboratories Net Sales by Segments; 2016 (Percentage, %)
Figure 37: Medtronic Net Sales; 2012-2016 (THE US$ Billion)
Figure 38: Medtronic Net Sales by Segments; 2016 (Percentage, %)
Figure 39: Medtronic Net Sales by Regions; 2016 (Percentage, %)
LIST OF TABLES
Table 1: Types of Mitral Regurgitation
Table 2: MR Surgery Class and Level
Table 3: Comparison of Aortic Valve and Mitral Valve
Table 4: Companies in the Global TMVR Market
Table 5: Global TMVR Market Players by Mitral Valve Repair Devices
Table 6: Key Players in the Global TMVR Market: Overview
Table 7: Design Comparison of the Devices of Key Players in the Global TMVR Market
Table 1: Types of Mitral Regurgitation
Table 2: MR Surgery Class and Level
Table 3: Comparison of Aortic Valve and Mitral Valve
Table 4: Companies in the Global TMVR Market
Table 5: Global TMVR Market Players by Mitral Valve Repair Devices
Table 6: Key Players in the Global TMVR Market: Overview
Table 7: Design Comparison of the Devices of Key Players in the Global TMVR Market
